Novartis Pharmaceuticals Corporation, Basel, Switzerland.
AstraZeneca, Cambridge, UK.
Genet Epidemiol. 2024 Feb;48(1):42-55. doi: 10.1002/gepi.22542. Epub 2023 Nov 28.
Rare-variants (RVs) genetic association studies enable researchers to uncover the variation in phenotypic traits left unexplained by common variation. Traditional single-variant analysis lacks power; thus, researchers have developed various methods to aggregate the effects of RVs across genomic regions to study their collective impact. Some existing methods utilize a static delineation of genomic regions, often resulting in suboptimal effect aggregation, as neutral subregions within the test region will result in an attenuation of signal. Other methods use varying windows to search for signals but often result in long regions containing many neutral RVs. To pinpoint short genomic regions enriched for disease-associated RVs, we developed a novel method, DYNamic Aggregation TEsting (DYNATE). DYNATE dynamically and hierarchically aggregates smaller genomic regions into larger ones and performs multiple testing for disease associations with a controlled weighted false discovery rate. DYNATE's main advantage lies in its strong ability to identify short genomic regions highly enriched for disease-associated RVs. Extensive numerical simulations demonstrate the superior performance of DYNATE under various scenarios compared with existing methods. We applied DYNATE to an amyotrophic lateral sclerosis study and identified a new gene, EPG5, harboring possibly pathogenic mutations.
罕见变异(RVs)的遗传关联研究使研究人员能够发现常见变异无法解释的表型特征的变化。传统的单变异分析缺乏效力;因此,研究人员开发了各种方法来聚合基因组区域中 RVs 的效应,以研究它们的集体影响。一些现有的方法利用基因组区域的静态划分,这通常导致效应聚合效果不佳,因为测试区域内的中性亚区会导致信号衰减。其他方法使用不同的窗口来搜索信号,但通常会导致包含许多中性 RVs 的长区域。为了精确定位富含与疾病相关的 RVs 的短基因组区域,我们开发了一种新方法,即动态聚合测试(DYNATE)。DYNATE 以动态和分层的方式将较小的基因组区域聚合到较大的区域中,并对疾病相关性进行多次测试,以控制加权错误发现率。DYNATE 的主要优势在于其能够识别富含与疾病相关的 RVs 的短基因组区域的强大能力。广泛的数值模拟表明,与现有方法相比,DYNATE 在各种情况下的表现都更为优越。我们将 DYNATE 应用于肌萎缩侧索硬化症研究中,鉴定出一个新基因 EPG5,该基因可能含有致病性突变。